Dear Healthcare Professional Letter Janssen Jan[removed]

First Page		Document Content
Pharmacology Pharmaceutical sciences Enantiopure drugs Pyrrolidines Doripenem Imipenem Ventilator-associated pneumonia MedWatch Adverse Event Reporting System Carbapenem antibiotics Food and Drug Administration Medicine		Dear Healthcare Professional Letter Janssen Jan[removed] Add to Reading List Source URL: www.fda.gov Download Document from Source Website File Size: 347,59 KB Share Document on Facebook

	ARTICLE Neonatal Deaths After Hepatitis B Vaccine The Vaccine Adverse Event Reporting System, Manette T. Niu, MD; Marcel E. Salive, MD, MPH; Susan S. Ellenberg, PhD DocID: 1sU4r - View Document
	84521booklet 1_TK-letter-size DocID: 1qPpC - View Document
	QuarterWatch Monitoring FDA MedWatch Reports Why Reports of Serious Adverse Drug Events Continue to Grow October 3, 2012 Data from 2012 Quarter 1 DocID: 1p1ui - View Document
	YELLOW FEVER VACCINE ADVERSE EVENT REPORTING SYSTEM PATIENT IDENTITY KEPT CONFIDENTIAL WEBSITE: www.enivd.de E-MAIL: Phone: ++For internal Use Only Robert Koch Institut, Nordu DocID: 1eA92 - View Document
	YELLOW FEVER VACCINE ADVERSE EVENT REPORTING SYSTEM PATIENT IDENTITY KEPT CONFIDENTIAL WEBSITE: www.enivd.de E-MAIL: FAX: ++For internal Use Only Robert Koch Institut, Nordufer 20 DocID: 1drvk - View Document